Genentech Inc reported profit rises and sales top estimates

Genentech Inc reported on Tuesday that sales of its cancer drug Avastin topped Wall Street estimates and its shares rose more than 3 percent, despite third-quarter earnings that fell short of analyst expectations due to higher costs.
U.S. sales of Avastin, widely considered the most important barometer of Genentech’s growth, rose 18 percent to $704 million, [...]

Genmab Reaches Milestone in Ofatumumab Collaboration

Genmab A/S announced today it has reached the sixth milestone for ofatumumab under the terms of its collaboration with GlaxoSmithKline . A milestone payment of approximately DKK 29 million was triggered by the first patient receiving treatment in the ofatumumab Phase I study in relapsed/refractory follicular non-Hodgkin’s lymphoma and chronic lymphocytic leukemia in Japan.
Ofatumumab is [...]

Evotec Announces Phase I Initiation With P2X7 Antagonist

Evotec AG announced today that Phase I clinical studies for its proprietary, small molecule P2X7 receptor antagonist have been initiated.
The P2X7 receptor is an ATP-gated ion channel primarily expressed on cells of the immune system and is thought to play an important role in inflammatory processes through the regulation of a number of proinflammatory cytokines. [...]

I loved neuroscience nursing, and I didn’t want to leave it

My path to nursing was long and circuitous. I graduated from nursing school as a registered nurse when I was 36 years old. Since becoming a nurse, I have worked in skilled care, behavioral health, med-surg, neuroscience and ICU step-down. I currently work in an orthopedic spine surgeon’s clinic as a nurse clinician.
I experienced my [...]